منابع مشابه
Long-term use of bisphosphonates in osteoporosis
OBJECTIVES To report and describe the management and response to treatment of patients referred to the osteoporosis clinic after prolonged use of bisphosphonate BPs) (4 years and more) with and without new fracture (any site) or any other new skeletal symptoms. Methods: This is a single center observational retrospective cohort study conducted from January 2009 to May 2016 in a tertiary center...
متن کاملintravenous bisphosphonates for postmenopausal osteoporosis
abstract numerous clinical studies have shown bisphoshonates (bps) to be useful and cost-effective options for the fractures prevention and postmenopausal bone loss. the use of oral bisphoshonates is an established option for managment of osteoporosis in postmenopausal women, but many of them complaint from gastrointestinal side effect or frequently dosed oral regimens. to improve upon the subo...
متن کاملBisphosphonates and glucocorticoid-induced osteoporosis: cons
During the use of glucocorticoids (GCs), both vertebral and nonvertebral fracture risk are increased, due to the direct and indirect negative effects of GCs on bone, muscles, and the activity of the underlying inflammatory diseases. Inhibition of bone formation and increased apoptosis of osteocytes play a consistent and crucial role in the pathogenesis of glucocorticoid-induced osteoporosis (GI...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Spine Journal
سال: 2003
ISSN: 0940-6719,1432-0932
DOI: 10.1007/s00586-003-0622-z